Glimimark MP1 Tablet 10's
Rs. 59.07
Title
Glimimark MP1 Tablet 10's
Prescription drug
Composition
: Glimepiride 1 mg + Metformin 500 mg + Pioglitazone 15 mg (by analogy with Glimfirst MP1)
About: Glimimark MP1 is a triple antidiabetic tablet containing glimepiride, metformin, and pioglitazone for type 2 diabetes.
Usage Instructions: Generally taken once daily with meals as prescribed.
Benefits: Targets insulin resistance, secretion, and glucose production together for better glycemic control.
How it Works: Glimepiride increases insulin release; metformin reduces hepatic glucose and increases sensitivity; pioglitazone improves peripheral insulin sensitivity via PPAR‑γ activation.
Side Effects: Weight gain, edema, hypoglycemia, GI upset.
Safety Advice: Avoid in heart failure or severe liver disease; monitor weight and fluid status.
Storage: Store below 25°C away from moisture.
Usage Instructions: Generally taken once daily with meals as prescribed.
Benefits: Targets insulin resistance, secretion, and glucose production together for better glycemic control.
How it Works: Glimepiride increases insulin release; metformin reduces hepatic glucose and increases sensitivity; pioglitazone improves peripheral insulin sensitivity via PPAR‑γ activation.
Side Effects: Weight gain, edema, hypoglycemia, GI upset.
Safety Advice: Avoid in heart failure or severe liver disease; monitor weight and fluid status.
Storage: Store below 25°C away from moisture.
₹59.07
MRP: ₹65.63
Save ₹6.56
(9%)
Inclusive of all taxes
Quantity
Fresh Stock
Guaranteed
Guaranteed
Secure & Hygienic
Packaging
Packaging
Verified & Trusted
Supplements
Supplements
Secure
Payment
Payment
About: Glimimark MP1 is a triple antidiabetic tablet containing glimepiride, metformin, and pioglitazone for type 2 diabetes.
Usage Instructions: Generally taken once daily with meals as prescribed.
Benefits: Targets insulin resistance, secretion, and glucose production together for better glycemic control.
How it Works: Glimepiride increases insulin release; metformin reduces hepatic glucose and increases sensitivity; pioglitazone improves peripheral insulin sensitivity via PPAR‑γ activation.
Side Effects: Weight gain, edema, hypoglycemia, GI upset.
Safety Advice: Avoid in heart failure or severe liver disease; monitor weight and fluid status.
Storage: Store below 25°C away from moisture.
Usage Instructions: Generally taken once daily with meals as prescribed.
Benefits: Targets insulin resistance, secretion, and glucose production together for better glycemic control.
How it Works: Glimepiride increases insulin release; metformin reduces hepatic glucose and increases sensitivity; pioglitazone improves peripheral insulin sensitivity via PPAR‑γ activation.
Side Effects: Weight gain, edema, hypoglycemia, GI upset.
Safety Advice: Avoid in heart failure or severe liver disease; monitor weight and fluid status.
Storage: Store below 25°C away from moisture.